Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLUSH: Bivalirudin vs Heparin in ECMO
NCT05959252Phase 2Recruiting
- Sponsor
- Sydney Local Health District
- Start
- May 2024
- Primary completion
- Jun 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bivalirudin in extracorporeal membrane oxygenation complication, sponsored by Sydney Local Health District. Started May 2024; status: recruiting.
02
Drugs
bivalirudin
03
Conditions
extracorporeal membrane oxygenation complication
Beyond the preview
Go deeper on NCT05959252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05959252.